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Summary. A general mechanism is recognized that can cause specific enzymatic activity at interphases. It consists qf
2 proteins bound in close juxtaposition at a micelle or membrane.surface. One, the enzyfire sensu strictu, bears the active
site, the other, the paraenzyme, is essential for generation or specific modification of the enzymatic activity,
It is the purpose of this report to draw attention to a the enzymatic activity, however, is governed by the
kind of interaction between protein molecules and an presence of the second protein molecule, called the para-
interface, that can regulate, or even generate, en- enzyme. For this kind of interaction we suggest the name
zyrnatic activity. The basic unit of this concept consists
oi 2 different protein molecules adsorbed neit to each
other onto an interface. This configuration constitutes
an enzy'matically active moiety; Tbe active site is present 1 present address: Department of Cardiology, St. Annadal Hos-
on one of tire 2 molecules, called the active site carrier; pital, Maastricht, The Netherlands.
Enzymatic activities generated. by paratopic interaction
Active site carrier Para-enzyme Substrate Product
Phospholipid micelle Factor X' Factor Va Prothrombin Thrombin
Phospholipid micelle Factor IXo Factor VIII" Factor X Factor Xn
Erythrocyte surface Cl" C1q and antibody C4 and, C2 C4. and, C'2,
Erythrocyte surface C2" C4" C3 C3c
TUA-particles F1 F" ATP ADP*Pr
( Rutamycin-sensitive)
Phospholipid - Fn SDH cyt. b Ubiquinone Ubiquinone
Oxidised Reduced
(TTB-sensitive)
Specialia l rxppnrpNr l - l  33 /7852
paratopic interaction (from the greek para - next and
topos - place). It is fundamentally different from all-
osteric interaction2'3 in that it occurs at an interface
only and from allotopic interactiona in that an interaction .
between proteins is essential.
Materials and methoils. Paratopic interaction in general is
recognized by a) solubilizing the intact systeml6-1s, w-hich
step can be omitted in the systems existing in blood plasma
as they are already in a solubilized form. Then b) separa-
t ion cf the consti tuents6-8'11'13'16'16'20. c) Reconsti tut ing
the system and estimating the activity as a function of
the nature and amounts of components added 6' 7' s' 10' 15-20.
For the experimental details, the reader is referred to the
original literature.
Results and, discussioz. Perhaps the best documented of
paratopic interactions is encountered in the generation
qf the enzyme prothrombinase, which catalyses the con-
version of prothrombin (blood coagulation factor II) into
thrombin. It has been suggested that prothrombinase
consists of factor X" and factor V" (the subscript a denotes
the activated factor) adsorbed next to each other onto a
phospholopid surface. The evidence for this is in short:
i) the minimal requirement for the generation of pro-
thrombinase activity is the simultaneous presence of a
phospholipid suspension, Ca ions and 2 proteins: the blood
coagulation factor X. and V&6; b) when both proteins are
bound to the same micelle, prothrombinase activity gen-
eratesT'8; c) the kinetics for the formation of prothrom-
binase activity are in accordance with the model pro-
posed e.
In the prothrombinase complex, the active site is located
in the factor X" molecule, because a) pure factor Xa has
a small but detectable prothrombinase action that can
be increased 1000fold by addition of phospholipid and
factor Vr. Phospholipid and factor Va have no prothrom-
binase action either alone or in combinationlo; b) factor
X" is an esterase that can split synthetic esters (e.g.
tosylargininemethylester) and that can be inhibited by
diisopropylfluorophosphate. No enzymatic properties of
factor V" have been found1l.
Another example oI paratopic interaction is tlre enzyme
that converts factor X into its activated form via the
intrinsic blood coagulation pathway. It consists of the
coagulation factors IXu and VIIIr adsorbed onto a phos-
ptrotlpia micelle12. Factor IXn is the active site here and
factor VIII" is the paraenzyme. Patatopic interactrons
are not restricted to the blood coagulation reactions.
The complement component C1" is a proesterase which,
when bound to a cell surface via C1n and one IgM or 2
adjacent IgG antibody molecules, develops into an active
"s{er"re. 
The natural substrates of this esterase are the
comolement factors C4 and C2 t}:'at are converted into
actiie forms. The latter 2 components are capable of
combining and can also be adsorbed onto a cell surface.
A surface bound enzyme thEn-.esults tftat ian convert
still another complement factot viz. C3 into its activated
form (see also the tablels-l5).
From the work oI Racker and colleagues, it can be seen
that paratopic interactions must also play a role in the
composition of the enzyme system, catalyzing oxidative
phosphorylation. In this work it is shown that among
ottt"i* ttrl protein fraction F, and Fo can be prepared
from the inner membrane of beefheart mitochondria' Ft
has ATPase activity, but only when combined with Fo
and a particulate fraction from the inner mitochondrial
membrine called TUA particles, this ATPase becomes
sensitive to rutamycin (or oligomycin) as in the intact
mitochondrion 16-18.
A 6th example can be found in the mitochondrion' Isolated
succinate dehydrogenase (SDH) only accepts ubiquinone
as a substrate-and is only sensitive to inhibition by 4'4'4-
trifluoro-1-(2-thienyl)-1.3-butanedione (TTB) when
together with cytochrome b and particles consisting of
phospholipids and coupling factor VI. The mode of in-
teraction of active site carrier and para enzyme ls unknown'
Covalent bonding is unlikely to play a role, as most of the
complexes described readily dissociate and recombine'
Quaiernary constraints analogous to these postulated 
by
Monod et al.3 in allosteric enzymes, but in this case
alymlqgtrleal, may be brought about in the ac-tive site
carrie? by the paraenzyme. The adsorption may serve
a" r -".tts of orientating the molecules, and in itself may
modify the tertiary structure of the protein moieties and
hence influence their interactron.
Alternatively, for those allotopic complexes having a
proteolytic action, one can imagine that iittle or nc-r
interaciion between paraenzyme and active site carrier
takes place, but that the substrate is more favourably
bound to the complex than to the single enzyme. The
obseivation by Esnouf that the esterolytic properties of
{actor X" have not been enhanced by the formation of a
prothrombinase complex hints in this direction20-
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